Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 19,70119,720 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Systemic delivery of siRNA by Nanosac for checkpoint blockade immunotherapy of head and neck squamous cell cancer
NATIONAL CANCER INSTITUTE Purdue University United States 2021 – 2025

ABSTRACT Head and neck cancer is currently treated by concomitant chemotherapy and radiation, but local recurrence and metastatic disease remain a concern. In particular, there is...

$5.77M
USD
Completed NON-SBIR/STTR RPGS
Development of multifunctional drug and immune modulator delivery nanoparticles for the treatment of cancer patients with comorbid atherosclerosis
NATIONAL CANCER INSTITUTE Emory University United States 2021 – 2025

Project Summary Cancer and cardiovascular disease are leading causes of death in the United States. Given the high percentage of cancer patients with co-existing atherosclerosis, t...

$5.32M
USD
Completed NON-SBIR/STTR RPGS
Imaging Modulation of Immune Phenotype
NATIONAL CANCER INSTITUTE Stanford University United States 2021 – 2026

Imaging and modulation of immunophenotype Most importantly, we have created TLR delivery nanotherapeutics and find that TLR NPs combined with aCD40, aPD-1 and aCTL4 (abbreviated as...

$6.41M
USD
Completed TRAINING, INSTITUTIONAL
Integrated Training in Quantitative and Experimental Cancer Systems Biology
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2021 – 2026

Project Summary There is an outstanding need for a national cadre of quantitatively sophisticated oncologists, with deep training in both biological aspects of cancer and computati...

$4.18M
USD
Completed NON-SBIR/STTR RPGS
Targeting cholesterol metabolism and replication stress response in cancer therapy
NATIONAL CANCER INSTITUTE Ohio State University United States 2021 – 2026

Project Summary: Lung cancer is the leading cause of cancer deaths in both men and women. Non-small cell lung cancer (NSCLC) accounts for large majority of lung cancer diagnoses, a...

$3.5M
USD
Completed TRAINING, INDIVIDUAL
Dysregulation of Liver Macrophages in Pancreatic Cancer
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2024

PROJECT SUMMARY Pancreatic ductal adenocarcinoma (PDAC) is the third-leading cause of cancer-related deaths in the United States. Metastasis is the major cause of mortality for pat...

$350.4K
USD
Completed NON-SBIR/STTR RPGS
Understanding affective processing of scientific evidence to promote informed choice for breast cancer screening
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2021 – 2026

Project Summary/Abstract Cancer screening for the right patients at the right level of cancer risk can save lives, but over the last several years many expert groups have de-intens...

$6.22M
USD
Completed TRAINING, INDIVIDUAL
Identifying targets for combination therapy with FOLFIRINOX and investigating cell polarity loss as a potential driver of invasion in basal-like PDAC
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2021 – 2024

Abstract Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease with a dismal five-year survival rate of 9% even with current treatments. There are two molecular tumor subtype...

$361.1K
USD
Completed TRAINING, INDIVIDUAL
The effect of epigenetic DNA methylation on the progression of HPV-associated precancerous cervical lesions
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2021 – 2025

PROJECT SUMMARY Reducing morbidity and mortality due to invasive cervical cancer (ICC) is a global health priority, which can be accomplished in part by improving the timely detect...

$397.2K
USD
Completed NON-SBIR/STTR RPGS
Role of Erbb3 kinase activity in colorectal tumorigenesis.
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2021 – 2026

The overarching goals of this proposal are to determine if Erbb3 kinase plays a critical role in colorectal tumorigenesis and to test if colorectal cancer with oncogenic Erbb3 muta...

$4.26M
USD
Completed NON-SBIR/STTR RPGS
Role of extracellular matrix proteins and tumor stroma in DNA repair and cancer progression
NATIONAL CANCER INSTITUTE Beth Israel Deaconess Medical Center United States 2021 – 2026

PROJECT SUMMARY Pancreatic ductal adenocarcinoma (PDA) is the fourth lethal cancer in the U.S. with a 5-year survival rate of only ~10%. The mainstay of therapy in PDA is chemother...

$3.92M
USD
Completed NON-SBIR/STTR RPGS
Targeting AR and AR-Variants in Castration-Resistant Prostate Cancer
NATIONAL CANCER INSTITUTE Texas A&M University Health Science Ctr United States 2021 – 2026

Project Summary/Abstract Current AR inhibitors (enzalutamide and abiraterone) inhibit either the conversion of androgen to dihydrotestosterone (DHT), block androgen binding to andr...

$4.49M
USD
Completed NON-SBIR/STTR RPGS
Targeting MUC5AC mucin in breast cancer brain metastasis
NATIONAL CANCER INSTITUTE University of Nebraska Medical Center United States 2021 – 2026

Abstract Breast cancer (BC) brain/central nervous system (CNS) metastasis is associated with poor survival among U.S. women, with 30-40% of these cases reported as triple receptor-...

$4.52M
USD
Completed NON-SBIR/STTR RPGS
Polyunsaturated fatty acids and colorectal tumor risk: a molecular and genetic epidemiology study
NATIONAL CANCER INSTITUTE Vanderbilt University Medical Center United States 2021 – 2025

PROJECT SUMMARY/ABSTRACT Arachidonic acid, a long-chain ω-6 polyunsaturated fatty acid (PUFA), has been demonstrated to affect carcinogenesis in animal and in vitro studies. The ef...

$349.7K
USD
Completed TRAINING, INDIVIDUAL
Effects of GPCR trafficking on the spatiotemporal control of signaling
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2023

Project Summary/Abstract G protein coupled receptors (GPCRs) constitute a family of signaling receptors that regulate essentially every physiological process. Recent studies have b...

$496.6K
USD
Completed NON-SBIR/STTR RPGS
Targeting vulnerabilities of PPM1D-mutant gliomas
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2026

Project Summary/Abstract Diffuse midline gliomas (DMGs) are devastating brain tumors of childhood with no curative treatments. We and others have observed up to 15% of all DMGs to...

$3.96M
USD
Completed NON-SBIR/STTR RPGS
Energy Balance, mTOR pathway signaling, and breast cancer prognosis
NATIONAL CANCER INSTITUTE Ohio State University United States 2021 – 2026

Project Summary/Abstract The objective of this project is to understand the role of the mechanistic Target of Rapamycin (mTOR) pathway in the association between energy imbalance a...

$7.14M
USD
Completed NON-SBIR/STTR RPGS
Bayesian Network-Based Integrative Genomics Methods for Precision Medicine
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2025

Project Summary/Abstract Modern multi-platform genomic data sets contain substantial molecular information potentially useful for discovering new precision therapeutic strategies....

$4.34M
USD
Completed NON-SBIR/STTR RPGS
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2026

SUMMARY / ABSTRACT With current treatment options, the five-year survival rate of patients with glioblastoma (GBM) is only 5%. Oncolytic viruses are promising treatments against so...

$3.63M
USD
Completed NON-SBIR/STTR RPGS
Abbreviated Non-Contrast-Enhanced MRI for Breast Cancer Screening
NATIONAL CANCER INSTITUTE Stanford University United States 2021 – 2026

Project Abstract Overview: In 2020, over 276,000 women will be diagnosed with invasive breast cancer, and over 48,000 will die from it. The ultimate goal of this project is to prov...

$6.68M
USD